MR imaging of benign focal liver lesions

Magnetic Resonance Imaging Clinics of North America

Volumn 18, Issue 3, 2010, Pages 403-419

  Ba Ssalamah, Ahmed ^a   Baroud, Susanne ^a   Bastati, Nina ^a   Qayyum, Aliya ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1.5T and 3T; Benign focal liver lesions; MRI; MRI contrast material; MRI techniques

Indexed keywords

FERUCARBOTRAN; GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOLINIUM; GADOXETIC ACID; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

BILIARY TRACT TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DRUG TUMOR LEVEL; FOCAL LIVER LESION; HAMARTOMA; HEPATOGRAPHY; HUMAN; IMAGE PROCESSING; LIVER ADENOMA; LIVER BIOPSY; LIVER CYST; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; LIVER HYDATID CYST; LIVER INJURY; LIVER PARENCHYMA; LIVER STRUCTURE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERFUSION WEIGHTED IMAGING; REVIEW; THREE DIMENSIONAL IMAGING;

CONTRAST MEDIA; CYSTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING;

EID: 78649257735     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2010.08.001     Document Type: Review

References (75)

1. Winterer J.T., Kotter E., Ghanem N., et al. Detection and characterization of benign focal liver lesions with multislice CT. Eur Radiol 2006, 16(11):2427-2443.
2. Schwartz L.H., Gandras E.J., Colangelo S.M., et al. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999, 210(1):71-74.
3. Mueller G.C., Hussain H.K., Carlos R.C., et al. Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation. AJR Am J Roentgenol 2003, 180(3):673-680.
4. Ba-Ssalamah A., Schima W., Schmook M.T., et al. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 2002, 179(6):1447-1456.
5. Caseiro-Alves F., Brito J., Araujo A.E., et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol 2007, 17(6):1544-1554.
6. Baudendistel K.T., Heverhagen J.T., Knopp M.V. Radiologe 2004, 44(1):11-18. [in German].
7. Choi J.S., Kim M.J., Choi J.Y., et al. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 2010, 20(5):1052-1060.
8. Dobritz M., Radkow T., Nittka M., et al. Rofo 2002, 174(6):738-741. [in German].
9. Ba-Ssalamah A., Uffmann M., Saini S., et al. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 2009, 19(2):342-357.
10. Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics 2009, 29(6):1797-1810.
11. Griswold M.A., Jakob P.M., Heidemann R.M., et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002, 47(6):1202-1210.
12. Lee V.S., Lavelle M.T., Rofsky N.M., et al. Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. Radiology 2000, 215(2):365-372.
13. Semelka R.C., Helmberger T.K. Contrast agents for MR imaging of the liver. Radiology 2001, 218(1):27-38.
14. Ba-Ssalamah A., Happel B., Kettenbach J., et al. Radiologe 2004, 44(12):1170-1184. [in German].
15. Bluemke D.A., Weber T.M., Rubin D., et al. Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol. Radiology 2003, 228(2):457-464.
16. Gandhi S.N., Brown M.A., Wong J.G., et al. MR contrast agents for liver imaging: what, when, how. Radiographics 2006, 26(6):1621-1636.
17. Ba-Ssalamah A., Heinz-Peer G., Schima W., et al. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000, 11(6):665-672.
18. Ba-Ssalamah A., Fakhrai N., Matzek W.K., et al. Magnetic resonance imaging of liver malignancies. Top Magn Reson Imaging 2007, 18(6):445-455.
19. Seale M.K., Catalano O.A., Saini S., et al. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009, 29(6):1725-1748.
20. Horton K.M., Bluemke D.A., Hruban R.H., et al. CT and MR imaging of benign hepatic and biliary tumors. Radiographics 1999, 19(2):431-451.
21. Mortele K.J., Ros P.R. Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 2001, 21(4):895-910.
22. Elsayes K.M., Narra V.R., Yin Y., et al. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics 2005, 25(5):1299-1320.
23. Mosetti M.A., Leonardou P., Motohara T., et al. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques. J Magn Reson Imaging 2003, 18(2):210-215.
24. Bae K.T., Tao C., Zhu F., et al. MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clin J Am Soc Nephrol 2009, 4(4):719-725.
25. Kadoya M., Matsui O., Nakanuma Y., et al. Ciliated hepatic foregut cyst: radiologic features. Radiology 1990, 175(2):475-477.
26. Fang S.H., Dong D.J., Zhang S.Z. Imaging features of ciliated hepatic foregut cyst. World J Gastroenterol 2005, 11(27):4287-4289.
27. Quan X.Y., Sun X.J., Yu Z.J., et al. Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal hepatic lesions: a quantitative study in 56 cases. Hepatobiliary Pancreat Dis Int 2005, 4(3):406-409.
28. Koike N., Cho A., Nasu K., et al. Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions. World J Gastroenterol 2009, 15(46):5805-5812.
29. Inan N., Arslan A., Akansel G., et al. Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver. AJR Am J Roentgenol 2007, 189(5):1031-1036.
30. Garcia-Diez A.I., Ros Mendoza L.H., Villacampa V.M., et al. MRI evaluation of soft tissue hydatid disease. Eur Radiol 2000, 10(3):462-466.
31. Czermak B.V., Akhan O., Hiemetzberger R., et al. Echinococcosis of the liver. Abdom Imaging 2008, 33(2):133-143.
32. Parsak C.K., Demiryurek H.H., Inal M., et al. Alveolar hydatid disease: imaging findings and surgical approach. Acta Chir Belg 2007, 107(5):572-577.
33. Sezgin O., Altintas E., Saritas U., et al. Hepatic alveolar echinococcosis: clinical and radiologic features and endoscopic management. J Clin Gastroenterol 2005, 39(2):160-167.
34. Kilickesmez O., Bayramoglu S., Inci E., et al. Value of apparent diffusion coefficient measurement for discrimination of focal benign and malignant hepatic masses. J Med Imaging Radiat Oncol 2009, 53(1):50-55.
35. Cook J.R., Pfeifer J.D., Dehner L.P. Mesenchymal hamartoma of the liver in the adult: association with distinct clinical features and histological changes. Hum Pathol 2002, 33(9):893-898.
36. Zen Y., Terahata S., Miyayama S., et al. Multicystic biliary hamartoma: a hitherto undescribed lesion. Hum Pathol 2006, 37(3):339-344.
37. Ryu Y., Matsui O., Zen Y., et al. Multicystic biliary hamartoma: imaging findings in four cases. Abdom Imaging August 15, 2009, [Epub ahead of print].
38. Volk M., Strotzer M., Lenhart M., et al. Frequency of benign hepatic lesions incidentally detected with contrast-enhanced thin-section portal venous phase spiral CT. Acta Radiol 2001, 42(2):172-175.
39. Vilgrain V., Boulos L., Vullierme M.P., et al. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 2000, 20(2):379-397.
40. Bader T.R., Braga L., Semelka R.C. Exophytic benign tumors of the liver: appearance on MRI. Magn Reson Imaging 2001, 19(5):623-628.
41. Cappellani A., Zanghi A., Di Vita M., et al. Spontaneous rupture of a giant hemangioma of the liver. Ann Ital Chir 2000, 71(3):379-383.
42. Belli G., D'Agostino A., Fantini C., et al. Surgical treatment of giant liver hemangiomas by enucleation using an ultrasonically activated device (USAD). Hepatogastroenterology 2009, 56(89):236-239.
43. Hanafusa K., Ohashi I., Himeno Y., et al. Hepatic hemangioma: findings with two-phase CT. Radiology 1995, 196(2):465-469.
44. Nelson R.C., Chezmar J.L. Diagnostic approach to hepatic hemangiomas. Radiology 1990, 176(1):11-13.
45. Danet I.M., Semelka R.C., Braga L., et al. Giant hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging 2003, 21(2):95-101.
46. Semelka R.C., Brown E.D., Ascher S.M., et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994, 192(2):401-406.
47. Montet X., Lazeyras F., Howarth N., et al. Specificity of SPIO particles for characterization of liver hemangiomas using MRI. Abdom Imaging 2004, 29(1):60-70.
48. McNicholas M.M., Saini S., Echeverri J., et al. T2 relaxation times of hypervascular and non-hypervascular liver lesions: do hypervascular lesions mimic haemangiomas on heavily T2-weighted MR images?. Clin Radiol 1996, 51(6):401-405.
49. Aibe H., Hondo H., Kuroiwa T., et al. Sclerosed hemangioma of the liver. Abdom Imaging 2001, 26(5):496-499.
50. Sandrasegaran K., Akisik F.M., Lin C., et al. The value of diffusion-weighted imaging in characterizing focal liver masses. Acad Radiol 2009, 16(10):1208-1214.
51. Nguyen B.N., Flejou J.F., Terris B., et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999, 23(12):1441-1454.
52. Giannitrapani L., Soresi M., La Spada E., et al. Sex hormones and risk of liver tumor. Ann N Y Acad Sci 2006, 1089:228-236.
53. Powers C., Ros P.R., Stoupis C., et al. Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics 1994, 14(3):459-482.
54. Wanless I.R., Mawdsley C., Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985, 5(6):1194-1200.
55. Kim T., Hori M., Onishi H. Liver masses with central or eccentric scar. Semin Ultrasound CT MR 2009, 30(5):418-425.
56. Toshikuni N., Kawaguchi K., Miki H., et al. Focal nodular hyperplasia coexistent with hemangioma and multiple cysts of the liver. J Gastroenterol 2001, 36(3):206-211.
57. Attal P., Vilgrain V., Brancatelli G., et al. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology 2003, 228(2):465-472.
58. Wanless I.R., Albrecht S., Bilbao J., et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 1989, 2(5):456-462.
59. Kapp N., Curtis K.M. Hormonal contraceptive use among women with liver tumors: a systematic review. Contraception 2009, 80(4):387-390.
60. Lee P.J. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr 2002, 161(Suppl 1):S46-S49.
61. Rummeny E., Weissleder R., Sironi S., et al. Central scars in primary liver tumors: MR features, specificity, and pathologic correlation. Radiology 1989, 171(2):323-326.
62. Shortell C.K., Schwartz S.I. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991, 173(5):426-431.
63. Greaves W.O., Bhattacharya B. Hepatic adenomatosis. Arch Pathol Lab Med 2008, 132(12):1951-1955.
64. Grazioli L., Federle M.P., Ichikawa T., et al. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000, 216(2):395-402.
65. Wiener Y., Dushnitzky T., Slutzki S., et al. Synchronous bleeding of liver adenomatosis and possible relation to acoustic trauma. HPB (Oxford) 2001, 3(4):267-269.
66. Santambrogio R., Marconi A.M., Ceretti A.P., et al. Liver transplantation for spontaneous intrapartum rupture of a hepatic adenoma. Obstet Gynecol 2009, 113(2 Pt 2):508-510.
67. Farges O., Dokmak S. Malignant transformation of liver adenoma: an analysis of the literature. Dig Surg 2010, 27(1):32-38.
68. Bioulac-Sage P., Balabaud C., Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg 2010, 27(1):39-45.
69. Zucman-Rossi J., Jeannot E., Nhieu J.T., et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006, 43(3):515-524.
70. Prasad S.R., Wang H., Rosas H., et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics 2005, 25(2):321-331.
71. Bioulac-Sage P., Laumonier H., Couchy G., et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009, 50(2):481-489.
72. Barbier C., Denny P., Becker S., et al. J Radiol 1997, 78(12):1281-1284. [in French].
73. Grazioli L., Morana G., Kirchin M.A., et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005, 236(1):166-177.
74. Chung J.J., Kim M.J., Kim K.W. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?. J Magn Reson Imaging 2006, 23(5):706-711.
75. Vogl T.J., Hammerstingl R., Schwarz W., et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996, 198(3):881-887.